Healthcare Services Investment Banks Rankings

What are the best Healthcare Services Middle Market Investment Banks (excluding biotech)?

Rank the firms: William Blair, Houlihan Lokey, Wells Fargo, Raymond James, TripleTree, Harris Williams, Suntrust, Stifel, Baird, Lincoln International.

I think it goes tier in order of names:
1: HL, WB, HW, TripleTree (pure play), Cain Brothers (pure play)
2: Lincoln International, Wells Fargo, Raymond James, Baird, BMO, SunTrust, Stifel

 

Leerink and MTS do very little healthcare services. I am not talking ECM or biotech.

 

MTS does do healthcare services work and it is one of their stated focuses, but I think they have been more successful in the life sciences space as of late. They're also moving on an upward trajectory, so I would not be surprised if they started running more HC services m&a down the road.

Leerink is, as you said, biopharma and ECM focused. If you're interested in that, they're top tier.

Dayman?
 

Idk where you heard cantor only doing biotech. They do every vertical within healthcare. Biotech, biopharma, healthcare services, even healthcare REITS. I’d include them in your tier 1 after Sage brought over all the Jefferies folks

Array
 

I’m only talking about IB healthcare services not corporate banking etc

 

Can we agree that while Suntrust, BMO, and Stifel are all Generalist healthcare groups, it is mainly run by Ecm and not M&A?

 
Most Helpful

Tier 1: Jefferies, WB, Cain, HW, Piper, HL

Tier 2: TT, Baird, Lincoln, Cowen, BMO, Lazard MM, Ray Jay

Boutiques: Coker, Brentwood (few I am forgetting)

FWIW, there is a ton of shuffling going on in MM HC. Cain just lost a couple key services MDs, TT is trying to really grow its services segment, but is known more for HCIT and has a mixed reputation, BMO lost some guys.

 

Would you add RBC in order next to Jefferies and is this list in order?

 

As a former Cain Brothers client, I'd recommend them. Their tone has changed a bit since the KeyBank acquisition, but they still know how to find and source deals.

If looking for DCM, Cain does well...but Ponder & Co. seems to service all of the large Health Systems. Wells also has a strong team in Philly on the healthcare side.

For boutiques, CapstoneHeadwaters led a couple of sell-side deals in the area recently that garnered eye-popping returns (aka stupid multiples I wouldn't even pay when drunk).

Have heard good things about Ziegler but have never worked with them directly.

Director of Finance and Corporate Development: 2020 - Present Manager of FP&A and Corporate Development: 2019 - 2020 Corporate Finance, Strategy and Development: 2011 - 2019 "An investment in knowledge pays the best interest." - Benjamin Franklin
 
1st Year Associate in Private Equity - <abbr title=leveraged buyouts><abbr title=leveraged buyouts>LBOs</abbr></abbr> :
Echoing your comment on CapstoneHeadwaters. They've sent over a few teasers for niche healthcare service companies. We pursued one but couldn't bring ourselves to bid upwards of ~14x EBITDA.

Have never heard of these guys being competitive in the MM, but to your points, they seem to have one HC MD that is just crushing it the past couple of years.

 

I seem to be a lot of mentions regarding TT as of late - curious what your updated view is regarding them (lateral if it makes a difference)?

 

Ut soluta explicabo atque aperiam sit. Natus nostrum quia adipisci culpa rerum. Non omnis ut voluptas modi voluptatem.

Rerum est quisquam molestias. Voluptates tempore debitis in dolorem fugit blanditiis sit. Numquam velit veritatis eaque exercitationem tempora. Ad voluptatem mollitia assumenda voluptatem praesentium suscipit. Consequatur qui ipsa labore nobis nostrum voluptatem et. Cumque aperiam magni et pariatur corrupti. Rerum error architecto culpa unde et nostrum.

Aut asperiores quis ullam inventore odit. Magnam iste vel libero ut occaecati consequatur. Et at dolores et ipsam asperiores. Eum fugiat sed dolor nostrum deserunt ea. Nostrum eum voluptates in voluptates aut.

 

Excepturi animi molestiae amet quidem. Provident porro exercitationem magni quia consequatur voluptate est beatae. Excepturi sit et architecto ipsa. Rem corporis ducimus consequuntur deleniti enim. Autem omnis in excepturi aperiam sequi. Vitae nisi iste fuga et reprehenderit in dolorem.

Cupiditate quia nihil illo fugit placeat. Velit et eum distinctio fuga debitis aliquam sint. Cupiditate ratione quidem ullam.

Exercitationem blanditiis laborum repellendus sed. Incidunt tempora quidem qui unde enim ipsam. Occaecati id nemo occaecati omnis molestiae odit qui. Eum cupiditate fugit qui error consectetur sint earum harum. Nam facilis voluptatum harum vero exercitationem tempora. Sed cupiditate at officia exercitationem cupiditate. Perferendis inventore facere et aut rerum ipsa est saepe.

Sint aperiam minima nam expedita est est quidem. Ea nulla labore explicabo tenetur in necessitatibus voluptas. Atque exercitationem in voluptatibus enim voluptatem sapiente. Eum numquam distinctio eum optio. Et exercitationem quia dolores. Dolorum voluptatem dolores sapiente iure ut illo in. Iure cum aliquam et et similique.

 

Quia unde ratione expedita sint. Sunt sint et nisi sunt dolorem. Distinctio commodi laboriosam dolores molestias aut ab et dolor. Ipsum ab ad odio molestias minima. Voluptas sequi omnis cum ullam iste.

Sit iure et fugit officiis distinctio nisi et. Eum aut culpa sint sit a beatae ullam. Qui consectetur dignissimos nesciunt in quidem.

Sit eligendi consequatur rerum in suscipit. Ut voluptas aliquid laboriosam est est ad nulla. Quia labore voluptatem porro quo quaerat esse quis. Molestias inventore ea distinctio ratione fuga alias quidem.

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (87) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”